story of the week
Ribociclib Plus Endocrine Therapy for Premenopausal Women With HR+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ribociclib Plus Endocrine Therapy for Premenopausal Women With Hormone-Receptor-Positive, Advanced Breast Cancer (MONALEESA-7): A Randomised Phase 3 Trial
Lancet Oncol 2018 May 24;[EPub Ahead of Print], D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, L Chow, J Sohn, KS Lee, S Campos-Gomez, R Villanueva Vazquez, KH Jung, KG Babu, P Wheatley-Price, M De Laurentiis, YH Im, S Kuemmel, N El-Saghir, MC Liu, G Carlson, G Hughes, I Diaz-Padilla, C Germa, S Hirawat, YS LuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.